FR2174655A1 - - Google Patents

Info

Publication number
FR2174655A1
FR2174655A1 FR7207647A FR7207647A FR2174655A1 FR 2174655 A1 FR2174655 A1 FR 2174655A1 FR 7207647 A FR7207647 A FR 7207647A FR 7207647 A FR7207647 A FR 7207647A FR 2174655 A1 FR2174655 A1 FR 2174655A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7207647A
Other languages
French (fr)
Other versions
FR2174655B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAUVERNAY CTRE RECH
Original Assignee
MAUVERNAY CTRE RECH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE795735D priority Critical patent/BE795735A/xx
Application filed by MAUVERNAY CTRE RECH filed Critical MAUVERNAY CTRE RECH
Priority to FR7207647A priority patent/FR2174655B1/fr
Priority to CH270373A priority patent/CH556815A/fr
Priority to IL41619A priority patent/IL41619A/en
Priority to US05/336,357 priority patent/US3962238A/en
Priority to ZA731411A priority patent/ZA731411B/xx
Priority to JP48024754A priority patent/JPS4899127A/ja
Priority to ES412203A priority patent/ES412203A1/es
Priority to GB1037973A priority patent/GB1377327A/en
Priority to DE2310918A priority patent/DE2310918C3/de
Priority to NL7303117.A priority patent/NL153190C/xx
Priority to CA165,544A priority patent/CA1015360A/fr
Publication of FR2174655A1 publication Critical patent/FR2174655A1/fr
Application granted granted Critical
Publication of FR2174655B1 publication Critical patent/FR2174655B1/fr
Priority to CA304,367A priority patent/CA1048027A/fr
Priority to US06/015,752 priority patent/USRE30577E/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
FR7207647A 1972-03-06 1972-03-06 Expired FR2174655B1 (enExample)

Priority Applications (14)

Application Number Priority Date Filing Date Title
BE795735D BE795735A (fr) 1972-03-06 Nouvelles ethylenediamines substituees a activite cardiovasculaire
FR7207647A FR2174655B1 (enExample) 1972-03-06 1972-03-06
CH270373A CH556815A (fr) 1972-03-06 1973-02-20 Procede pour la preparation des propylamines.
IL41619A IL41619A (en) 1972-03-06 1973-02-26 N-propanolamine sites and their preparation
US05/336,357 US3962238A (en) 1972-03-06 1973-02-27 Ethers of n-propanol amine
ZA731411A ZA731411B (en) 1972-03-06 1973-02-28 Preparation of ethers of n-prpanolamine and use thereof
JP48024754A JPS4899127A (enExample) 1972-03-06 1973-03-01
ES412203A ES412203A1 (es) 1972-03-06 1973-03-01 Procedimiento para la preparacion de nuevos compuestos qui-micos de accion cardiovascular.
GB1037973A GB1377327A (en) 1972-03-06 1973-03-02 Ethers of n-propanolamine and preparation thereof
DE2310918A DE2310918C3 (de) 1972-03-06 1973-03-05 3-Isobutoxy-2-pyrrolidino-N-phenyl-N-benzylpropylamin, dessen Salze Verfahren zu deren Herstellung und Arzneimittel
NL7303117.A NL153190C (nl) 1972-03-06 1973-03-06 Werkwijze voor het bereiden van een van een 2,3- -diaminopropanolderivaat afgeleide ether met cardiovas- culaire werking alsmede werkwijze voor het bereiden van een geneesmiddel met cardiovasculaire werking onder toe- passing van de aldus verkregen ether.
CA165,544A CA1015360A (fr) 1972-03-06 1973-03-06 Ethylenediamines substituees a activite cardiovasculaire
CA304,367A CA1048027A (fr) 1972-03-06 1978-05-30 Ethylenediamines substituees a activite cardiovasculaire
US06/015,752 USRE30577E (en) 1972-03-06 1979-02-27 Ether of n-propanol amine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7207647A FR2174655B1 (enExample) 1972-03-06 1972-03-06

Publications (2)

Publication Number Publication Date
FR2174655A1 true FR2174655A1 (enExample) 1973-10-19
FR2174655B1 FR2174655B1 (enExample) 1975-08-01

Family

ID=9094658

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7207647A Expired FR2174655B1 (enExample) 1972-03-06 1972-03-06

Country Status (12)

Country Link
US (2) US3962238A (enExample)
JP (1) JPS4899127A (enExample)
BE (1) BE795735A (enExample)
CA (2) CA1015360A (enExample)
CH (1) CH556815A (enExample)
DE (1) DE2310918C3 (enExample)
ES (1) ES412203A1 (enExample)
FR (1) FR2174655B1 (enExample)
GB (1) GB1377327A (enExample)
IL (1) IL41619A (enExample)
NL (1) NL153190C (enExample)
ZA (1) ZA731411B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378024A1 (fr) * 1977-01-25 1978-08-18 Cerm Cent Europ Rech Mauvernay Nouvelle propylamine substituee, obtention et application
EP0138684A3 (en) * 1983-09-27 1985-06-19 Riom Laboratoires- C.E.R.M. "R.L.-Cerm" - (S.A.) 2-(n-pyrrolidino)-3-isobutoxy-n-phenyl-substituted n-benzylpropyl amines, their preparation and their pharmaceutical use

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2472567A1 (fr) 1979-12-28 1981-07-03 Cerm Cent Europ Rech Mauvernay Ethers de 1- (2-propynyloxy)-2-amino-3-propanol, leur preparation et leur application en therapeutique
BR8208033A (pt) * 1981-12-28 1983-11-22 Carter Wallace Processo quimico
US4417075A (en) * 1982-01-18 1983-11-22 Exxon Research And Engineering Co. Di-(Secondary and tertiaryalkylaminoalkoxy)alkanes
US4405811A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Severely sterically hindered tertiary amino compounds
US4405585A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary aminoether alcohols
US4405581A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for the selective removal of hydrogen sulfide from gaseous mixtures with severely sterically hindered secondary amino compounds
US4471138A (en) * 1982-01-18 1984-09-11 Exxon Research And Engineering Co. Severely sterically hindered secondary aminoether alcohols
US4483833A (en) * 1982-01-18 1984-11-20 Exxon Research & Engineering Co. Process for selective removal of H2 S from mixtures containing H22 with heterocyclic tertiary aminoalkanols
US4405580A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for selective removal of H2 S from mixtures containing H22 with tertiary amino azabicyclic alcohols
US4762934A (en) * 1982-01-18 1988-08-09 Exxon Research And Engineering Company Diaminoether compositions
US4405583A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for selective removal of H2 S from mixtures containing H22 using di-severely sterically hindered secondary aminoethers
US4405582A (en) * 1982-01-18 1983-09-20 Exxon Research And Engineering Co. Process for selective removal of H2 S from mixtures containing H22 using diaminoether solutions
US4508692A (en) * 1982-01-18 1985-04-02 Exxon Research & Engineering Co. Process for the selective removal of hydrogen sulfide from gaseous mixtures with strongly basic tertiary amino compounds
GB8330197D0 (en) * 1983-11-11 1983-12-21 Akzo Nv Ether of n-propanolamine derivative
EP0146159B1 (en) * 1983-11-11 1988-01-13 Akzo N.V. Ether of n-propanolamine derivative
US4727072A (en) * 1986-02-12 1988-02-23 Mcneilab, Inc. 3-alkoxy-2-aminopropylamines compositions and use as cardiovascular agents
US4758563A (en) * 1986-02-12 1988-07-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyamines, cardiovascular compositions and use
DE3726632A1 (de) * 1987-08-11 1989-05-18 Boehringer Mannheim Gmbh 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
DE3726633A1 (de) * 1987-08-11 1989-02-23 Boehringer Mannheim Gmbh Neue 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US4888335A (en) 1988-07-25 1989-12-19 Mcneilab, Inc. 3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5185362A (en) * 1988-09-14 1993-02-09 Mcneilab, Inc. Diphenylamine cardiovascular agents, compositions and use
JP3835763B2 (ja) 2002-08-19 2006-10-18 ファイザー・プロダクツ・インク 増殖亢進疾患のための組み合わせ治療
SG141430A1 (en) * 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
EP1796653A2 (en) * 2004-07-26 2007-06-20 Actelion Pharmaceuticals Ltd. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
BRPI0518300A2 (pt) * 2004-11-23 2008-11-11 Warner Lambert Co derivados de Ácido 7-(2h-pirazol-3-il)-3,5-diidràxi-heptanàico como inibidores da hmg co-a reductase para o tratamento de lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
WO2007050783A2 (en) * 2005-10-26 2007-05-03 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
TW200811101A (en) * 2006-07-14 2008-03-01 Ranbaxy Lab Ltd Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
WO2009032286A2 (en) 2007-09-06 2009-03-12 Nektar Therapeutics Al, Corporation Oligomer-calcium channel blocker conjugates
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2016098128A1 (en) 2014-12-16 2016-06-23 Council Of Scientific & Industrial Research Process for the preparation of bepridil

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH268689A (de) * 1947-07-01 1950-05-31 Spojene Farmaceuticke Z Narodn Verfahren zur Darstellung eines biologisch wirksamen Phenyläthylendiaminderivates.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2600301A (en) * 1948-06-04 1952-06-10 Smith Kline French Lab N-substituted-beta halo-ethyl amines
NL101813C (enExample) * 1955-04-09
GB1219609A (en) * 1968-07-19 1971-01-20 Koninklijke Pharma Fab Nv Diphenylmethoxyethylamino derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH268689A (de) * 1947-07-01 1950-05-31 Spojene Farmaceuticke Z Narodn Verfahren zur Darstellung eines biologisch wirksamen Phenyläthylendiaminderivates.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378024A1 (fr) * 1977-01-25 1978-08-18 Cerm Cent Europ Rech Mauvernay Nouvelle propylamine substituee, obtention et application
EP0138684A3 (en) * 1983-09-27 1985-06-19 Riom Laboratoires- C.E.R.M. "R.L.-Cerm" - (S.A.) 2-(n-pyrrolidino)-3-isobutoxy-n-phenyl-substituted n-benzylpropyl amines, their preparation and their pharmaceutical use

Also Published As

Publication number Publication date
DE2310918A1 (de) 1973-09-20
DE2310918C3 (de) 1980-07-03
JPS4899127A (enExample) 1973-12-15
FR2174655B1 (enExample) 1975-08-01
DE2310918B2 (de) 1979-10-25
CH556815A (fr) 1974-12-13
IL41619A (en) 1976-05-31
CA1048027A (fr) 1979-02-06
ZA731411B (en) 1974-04-24
US3962238A (en) 1976-06-08
NL153190C (nl) 1980-12-15
CA1015360A (fr) 1977-08-09
BE795735A (fr) 1973-06-18
ES412203A1 (es) 1975-12-01
GB1377327A (en) 1974-12-11
NL7303117A (enExample) 1973-09-10
USRE30577E (en) 1981-04-14
NL153190B (nl) 1977-05-16
IL41619A0 (en) 1973-04-30

Similar Documents

Publication Publication Date Title
FR2174655B1 (enExample)
JPS4932646A (enExample)
FR2176965B1 (enExample)
FR2186297B1 (enExample)
FR2208728B1 (enExample)
FR2194332A5 (enExample)
JPS5322798B2 (enExample)
JPS4978501A (enExample)
CS156583B1 (enExample)
FR2193914B3 (enExample)
JPS499408A (enExample)
JPS4932877U (enExample)
FR2197091B1 (enExample)
JPS4939649U (enExample)
CS156674B1 (enExample)
CS154514B1 (enExample)
JPS4933384U (enExample)
CS154521B1 (enExample)
JPS493269U (enExample)
CS154831B1 (enExample)
CS155427B1 (enExample)
JPS4995502U (enExample)
CS155440B1 (enExample)
CS156134B1 (enExample)
CH564924A5 (enExample)

Legal Events

Date Code Title Description
CD Change of name or company name